1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow PSEN1 Mutation: new trials by email Literature Review of PSEN1 Mutation trials Research Report on PSEN1 Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease Bromocriptine Mesilate, Placebos - Familial Alzheimer Disease (FAD), PSEN1 Mutation | Phase 1 / Phase 2 | Completed | Kyoto University | 8 | 2020-06-05 | 2025-08-29 |
Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Tauopathies (1)
Bromocriptine (1)
Kyoto University (1)
Japan (1)
Haruhiko Banno, MD, PhD (1) · Haruhisa Inoue, MD, PhD (1) · Hidekazu Tomimoto, MD, PhD (1)